ApprovalTrail

Approval · Notice of Compliance 31017 · 2023

ATIPAM: Notice of Compliance 31017

Issued June 21, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
31017
Date
June 21, 2023
Product type
Veterinary
Submission
Supplement to an Abbreviated New Drug Submission (SANDS), supplement
Submission class
Other
Reason
Manufacturing changes for drug product
Canadian reference product
ANTISEDAN (Orion Corporation)

Products in this notice

BrandDINStatus today
ATIPAMNot yet assigned—

Medicinal ingredients